Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

Market Cap	6.83B +28.5%
Revenue (ttm)	3.15B -25.5%
Net Income	2.22M
EPS	0.00
Shares Out	1.37B
PE Ratio	3,073.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,696,206
Average Volume	22,901,690
Open	4.45
Previous Close	4.87
Day's Range	4.45 - 5.07
52-Week Range	3.66 - 6.94
Beta	0.48
RSI	71.83
Earnings Date	Apr 24, 2026

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headq...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 6,586
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002424